|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 15/46 | |
| A61K 35/76 | |||
| A61P 35/00 | |||
| C07K 14/14 | |||
| C12N 15/86 | |||
| C12N 7/01 |
| (11) | Number of the document | 2132315 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08733587.3 |
| Date of filing the European patent application | 2008-03-11 | |
| (97) | Date of publication of the European application | 2009-12-16 |
| (45) | Date of publication and mention of the grant of the patent | 2015-07-15 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/CA2008/000483 |
| Date | 2008-03-11 |
| (87) | Number | WO 2008/110004 |
| Date | 2008-09-18 |
| (30) | Number | Date | Country code |
| 894425 P | 2007-03-12 | US | |
| 989568 P | 2007-11-21 | US |
| (72) |
COFFEY, Matthew C., CA
|
| (73) |
Oncolytics Biotech Inc.,
Suite 210 1167 Kensington Crescent N. W., Calgary, AB T2N 1X7,
CA
|
| (54) | REOVIRUSES HAVING MODIFIED SEQUENCES |
| REOVIRUSES HAVING MODIFIED SEQUENCES |